CASTEL SAN PIETRO, 5 July 2023- Medacta Group S.A. (‘Medacta,’ SIX: MOVE), a Swiss company featuring innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgeries, is pleased to announce the successful completion of the first MyPAO surgeries in Europe, leveraging Medacta’s long-term experience in CT-based planning and expanding the offer of patient-matched solutions for hip preservation procedures.
Designed in collaboration with a group of expert surgeons, MyPAO is an innovative and complete platform based on patient-matched technology to assist the surgeon during periacetabular osteotomy procedures.
The MyPAO Platform consists of a CT-based 3D preoperative planning report, 3D preoperative and postoperative bone models, cortical screws, and patient-specific realignment guides intended to assist in the realignment of the acetabular fragment during periacetabular osteotomies.
‘What I value the most about MyPAO is the surgical planning report, which allows me to visualize all the relevant preoperative parameters at a glance. The 3D coverage section of the report, together with 3D printed pre-op and post-op bone models, provides additional support to give a complete overview on how the realignment is going to look like,’ comments Dr. med. Panayiotis Christofilopoulos, Hôpital de La Tour (Meyrin, Geneva).
The MyPAO surgical planning report includes all the relevant preoperative parameters of the patient’s hip and a proposal for the realignment of the acetabulum, complete with a simulation of the corresponding postoperative parameters.
‘The MyPAO patient-specific guides are designed to control acetabulum realignment after I perform the osteotomies using my preferred technique. Unlike conventional P.A.O. procedures, the MyPAO guides allow for a faster and more precise correction, reduce X-ray exposure and replicate the preoperative planning. The guides fit well on the patient’s bones, making the positioning of the system safe and easy to use,’ comments Dr. Michel Rahmé, Rhéna Clinique de Strasbourg.
MyPAO is part of our MySolutions Personalized Ecosystem, an advanced network of digital solutions based on cutting-edge technologies designed to improve patient outcomes, healthcare efficiency, and sustainability.
MyPAO is supported by the comprehensive, tailored educational offerings provided by the M.O.R.E. Institute. With an international network of expert surgeons, the M.O.R.E. Institute is at the forefront of education on sports medicine procedures and products with personalized, high-level educational pathways. With Medacta, the surgeon is never alone when discovering new technologies.
Medacta International SA
Senior Director Global Marketing
Phone: +41 91 696 60 60
Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine. Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta’s innovation, forged by close collaboration with surgeon experts globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 50 countries. Follow us on Medacta TV, YouTube, LinkedIn, and Twitter.
Medacta Group Related Trademarks are registered at least in Switzerland. The products and services listed below may not be all-inclusive, and other Medacta products and services not listed below may be covered by one or more trademarks. The below products and services may be covered by additional trademarks not listed below. Note that Swiss trademarks may have foreign counterparts. MyPAO®, MySolutions™ Personalized Ecosystem.